About PhotoThera
PhotoThera is a company based in Carlsbad (United States) founded in 1997. It operates as a B2B. PhotoThera has raised $80.5 million across 2 funding rounds from investors including Warburg Pincus, Solstice Capital and The Vertical Group. PhotoThera operates in a competitive market with competitors including Avation, Tulavi Nerve Therapeutics, BioCircuit, RxFunction and Epineuron, among others.
- Headquarter Carlsbad, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$80.5 M (USD)
in 2 rounds
-
Latest Funding Round
$50 M (USD), Series D
May 01, 2009
-
Investors
Warburg Pincus
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of PhotoThera
PhotoThera has successfully raised a total of $80.5M across 2 strategic funding rounds. The most recent funding activity was a Series D round of $50 million completed in May 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PhotoThera
PhotoThera has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Warburg Pincus, Solstice Capital and The Vertical Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage private equity investments are pursued across diverse sectors.
|
Locked | Locked | Locked | |
|
Investments in early and late-stage US companies are made.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for PhotoThera
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PhotoThera
Investment portfolio details for PhotoThera
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PhotoThera
Detailed financials for PhotoThera
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Photothera Comparisons
Peer comparison for PhotoThera
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PhotoThera
PhotoThera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avation, Tulavi Nerve Therapeutics, BioCircuit, RxFunction and Epineuron, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable tibial nerve stimulation device treats overactive bladder symptoms.
|
|
| Locked | Locked | Locked |
Therapeutic devices for neurally mediated diseases are developed.
|
|
| Locked | Locked | Locked |
Non-invasive electrophysiology devices are developed to monitor peripheral nerves.
|
|
| Locked | Locked | Locked |
Wearable prostheses for sensory peripheral neuropathy patients are developed.
|
|
| Locked | Locked | Locked |
Medical devices for peripheral nerve injury treatment are provided.
|
|
| Locked | Locked | Locked |
Developer of bioimplant for peripheral nerve repair
|
Detailed competitors of PhotoThera
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Photothera
Complete news archive for PhotoThera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PhotoThera
PhotoThera was founded in 1997 and raised its 1st funding round 9 years after it was founded.
PhotoThera is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
PhotoThera is a funded company, having raised a total of $80.5M across 2 funding rounds to date.
PhotoThera, established in 1997 and currently in Dissolved stage, focuses on providing healthcare solutions, developing medical devices, laser therapy, and therapeutic devices. Provides advanced laser therapy solutions for healthcare applications. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
PhotoThera's top competitors include Avation, Tulavi Nerve Therapeutics and Epineuron.
PhotoThera has 6 investors. Key investors include Warburg Pincus, Solstice Capital, The Vertical Group, Hamilton BioVentures, and Delphi Ventures.